Viw Magazine

The Times


.

Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine

  • Written by Viw Magazine

Encouraging findings with immunotherapy aiming at ART-free virological control A significant step towards functional cure of HIV infection

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce the completion of a first-in-human novel therapeutic HIV vaccine, ICVAX, Phase I clinical trial with encouraging findings of exceptional safety and promising immunogenicity profiles.

Read more

LifeStyle

Human Hair Wigs: A Practical And Natural-Looking Hair Solution

Hair plays an important role in personal style, confidence, and self-expression. Whether experienc...

The SNUGGLES Cove: Premium 2-in-1 Hooded Pet Beds for Ultimate Comfort

Finding the right pet bedding can make a real difference to your pet’s comfort and daily routine. ...

Why Hurstville Tutoring Can Support Stronger Academic Performance

Education continues becoming more demanding as students manage complex curriculums, assessment pre...

Gold Coast Party Boats: The New Luxury Must-Have

In times of global uncertainty, overcrowded tourist areas, and unpredictable weather, Gen Z and yo...

hacklink hack forum hacklink film izle hacklink holiganbetonline casinos australiaonwinonline casino australiatipobetligobetyasadışı ilaç satışıThe Pokies Netbetasus girişjojobetdizipaldeneme bonusu veren sitelerGrandpashabetpashagamingjudi bolaturkbetSahabet xonline casino australiabest online casinos australiaroyal reelsroyalreelsonlinecasino.coroyal reels online casinoroyalreels.pokerroyal reels casinoligobetligobet girişdeneme bonusuthe pokies net onlineสล็อตjojobetz library livrosjojobetjojobetnakitbahisnakitbahisikimisliholiganbetjojobetcasibomcasibom